Gene profiles of a human alveolar epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: Identification of discriminating genetic markers and pathway analysis

Toxicology Letters

Volumn 185, Issue 1, 2009, Pages 16-22

  Verstraelen, Sandra ^a   Nelissen, Inge ^a   Hooyberghs, Jef ^a   Witters, Hilda ^a   Schoeters, Greet ^a,b   Van Cauwenberge, Paul ^c   Van Den Heuvel, Rosette ^a  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

A549; Alveolar epithelial cells; In vitro assay; Pathway analysis; Respiratory sensitization; Transcriptomics

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACROLEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ESTROGEN RECEPTOR; HEXACHLOROPLATINATE AMMONIUM; HEXAMETHYLENE DIISOCYANATE; MITOGEN ACTIVATED PROTEIN KINASE; PLATINUM DERIVATIVE; PREGNANE X RECEPTOR; PROTEIN P53; RETINOID X RECEPTOR; SALICYLIC ACID METHYL ESTER; TRIMELLITIC ANHYDRIDE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BINDING AFFINITY; CHEMOSENSITIZATION; CONTROLLED STUDY; DNA MICROARRAY; EXPOSURE; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS;

ACROLEIN; ANTIGENS, CD; CELL LINE; DINITROCHLOROBENZENE; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; PULMONARY ALVEOLI; SALICYLATES; SIGNAL TRANSDUCTION;

EID: 58349085727     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.11.017     Document Type: Article

References (30)

1. Abonyo B.O., Lebby K.D., Tonry J.H., Ahmad M., and Heiman A.S. Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells. Cytokine 36 (2006) 237-244
2. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47 (1991) 22-31
3. Bisset L.R., and Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr. Opin. Pulm. Med. 11 (2005) 35-42
4. Boverhof D.R., Billington R., Gollapudi B.B., Hotchkiss J.A., Krieger S.M., Poole A., Wiescinski C.M., and Woolhiser M.R. Respiratory sensitization and allergy: current research approaches and needs. Toxicol. Appl. Pharmacol. 226 (2008) 1-13
5. Burr J.S., Kimzey S.L., Randolph D.R., and Green J.M. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am. J. Respir. Cell Mol. Biol. 24 (2001) 563-568
6. Chu H.W., Jeyaseelan S., Rino J.G., Voelker D.R., Wexler R.B., Campbell K., Harbeck R.J., and Martin R.J. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J. Immunol. 174 (2005) 5713-5719
7. Fuchs B., and Braun A. Modulation of asthma and allergy by addressing toll-like receptor 2. J. Occup. Med. Toxicol. 3 1 (2008) S5
8. Gao H., and Ward P.A. STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin. Ther. Targets 11 (2007) 869-880
9. Hellings P.W., Vandenberghe P., Kasran A., Coorevits L., Overbergh L., Mathieu C., and Ceuppens J.L. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur. J. Immunol. 32 (2002) 585-594
10. Hooyberghs J., Schoeters E., Lambrechts N., Nelissen I., Witters H., Schoeters G., and Van Den Heuvel R. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol. Appl. Pharmacol. (2008)
11. Howard T.D., Postma D.S., Hawkins G.A., Koppelman G.H., Zheng S.L., Wysong A.K., Xu J., Meyers D.A., and Bleecker E.R. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J. Allergy Clin. Immunol. 110 (2002) 743-751
12. Hulette B.C., Ryan C.A., Gildea L.A., and Gerberick G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 209 (2005) 159-166
13. Jacobs J.J., Lehe C.L., Hasegawa H., Elliott G.R., and Das P.K. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp. Dermatol. 15 (2006) 432-440
14. Krummel M.F., and Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182 (1995) 459-465
15. Leach D.R., Krummel M.F., and Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271 (1996) 1734-1736
16. Li C.C., Zhang W.X., Chen X.F., Xie L.W., He Q.S., Hu X.G., Lin J., Li M.R., Wu R.X., and Zhang Z.X. Effect of macrophage inflammatory protein-1alpha and its mRNA on airway inflammation of mouse asthma model. Zhonghua Er Ke Za Zhi 42 (2004) 90-93
17. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., and Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174 (1991) 561-569
18. Paplinska M., Grubek-Jaworska H., and Chazan R. Role of eotaxin in the pathophysiology of asthma. Pneumonol. Alergol. Pol. 75 (2007) 180-185
19. Pardo A., Gibson K., Cisneros J., Richards T.J., Yang Y., Becerril C., Yousem S., Herrera I., Ruiz V., Selman M., and Kaminski N. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2 (2005) e251
20. Perkins D., Wang Z., Donovan C., He H., Mark D., Guan G., Wang Y., Walunas T., Bluestone J., Listman J., and Finn P.W. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156 (1996) 4154-4159
21. Tanino Y., Hizawa N., Konno S., Fukui Y., Takahashi D., Maeda Y., Huang S.K., and Nishimura M. Sequence variants of the secreted phosphoprotein 1 gene are associated with total serum immunoglobulin E levels in a Japanese population. Clin. Exp. Allergy 36 (2006) 219-225
22. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., and Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 (1995) 541-547
23. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5116-5121
24. Verstraelen S., Bloemen K., Nelissen I., Witters H., Schoeters G., and Heuvel R.V. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol. In Vitro 22 (2008) 1419-1431
25. Verstraelen S., Wens B., Hooyberghs J., Nelissen I., Witters H., Schoeters G., Cauwenberge P.V., and Heuvel R.V. Gene expression profiling of in vitro cultured macrophages after exposure to the respiratory sensitizer hexamethylene diisocyanate. Toxicol. In Vitro 22 (2008) 1107-1114
26. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., and Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 (1994) 405-413
27. Walunas T.L., Sperling A.I., Khattri R., Thompson C.B., and Bluestone J.A. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J. Immunol. 156 (1996) 1006-1013
28. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., and Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 (1995) 985-988
29. Wisnewski A.V., Liu Q., Liu J., and Redlich C.A. Glutathione protects human airway proteins and epithelial cells from isocyanates. Clin. Exp. Allergy 35 (2005) 352-357
30. Wisnewski A.V., Srivastava R., Herick C., Xu L., Lemus R., Cain H., Magoski N.M., Karol M.H., Bottomly K., and Redlich C.A. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am. J. Respir. Crit. Care Med. 162 (2000) 2330-2336